← FDA DRUG APPROVALS

FDA ANDA · ANDA089395

VINBLASTINE SULFATE

Sponsor: HIKMA

APPLICATION
ANDA089395
TYPE
ANDA
ORIGINAL APPROVAL
1987-04-09
LATEST ACTION
2002-08-22
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

VINBLASTINE SULFATEPrescription
VINBLASTINE SULFATE 10MG/VIAL · INJECTABLE · INJECTION

Approval history

2002-08-22Labeling · Supplement 9AP
2000-12-21Manufacturing (CMC) · Supplement 8AP
1997-09-05Labeling · Supplement 7AP
1994-02-25Manufacturing (CMC) · Supplement 6AP
1993-04-30Labeling · Supplement 5AP
1993-04-02Labeling · Supplement 4AP
1989-04-24Labeling · Supplement 3AP
1988-04-13Manufacturing (CMC) · Supplement 1AP
1988-04-13Manufacturing (CMC) · Supplement 2AP
1987-04-09OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →